Miro1 Protein

Miro1 (RHOT1) Protein

Pathway Diagram

```mermaid
flowchart TD
MIRO1["MIRO1<br/>Mitochondrial Rho GTPase"]

%% Mitochondrial dynamics and transport
DNM1L["DNM1L<br/>Dynamin-related<br/>protein 1"]
OPTN["OPTN<br/>Optineurin<br/>Autophagy receptor"]
CAT["CAT<br/>Catalase<br/>Antioxidant enzyme"]

%% Cellular processes
MitoTransport["Mitochondrial<br/>Transport"]
MitoDynamics["Mitochondrial<br/>Dynamics"]
Autophagy["Mitophagy<br/>Clearance"]
OxidativeStress["Oxidative<br/>Stress"]

%% Neurodegeneration processes
Inflammation["Neuroinflammation"]
Aging["Cellular<br/>Aging"]

%% Disease outcomes
Alzheimer["Alzheimer's<br/>Disease"]
Parkinson["Parkinson's<br/>Disease"]
ALS["Amyotrophic<br/>Lateral Sclerosis"]
MS["Multiple<br/>Sclerosis"]
TBI["Traumatic<br/>Brain Injury"]
Neurodegeneration["Neurodegeneration"]

%% Key pathway connections
MIRO1 -->|"regulates"| MitoTransport
MIRO1 -->|"controls"| MitoDynamics
DNM1L -->|"interacts_with"| MIRO1
OPTN -->|"interacts_with"| MIRO1
CAT -->|"interacts_with"| MIRO1

%% Protective mechanisms
MitoTransport -->|"maintains"| Autophagy
CAT -->|"reduces"| OxidativeStress
OPTN -->|"promotes"| Autophagy

%% Pathological processes
MitoDynamics -->|"dysfunction_leads_to"| OxidativeStress
OxidativeStress -->|"triggers"| Inflammation
MIRO1 -->|"activates"| Inflammation
MIRO1 -->|"regulates"| Aging

%% Disease associations
Inflammation -->|"contributes_to"| Alzheimer

Miro1 (RHOT1) Protein

Pathway Diagram

Overview

Miro1 (also known as RHOT1 or Miro-1) is a mitochondrial Rho GTPase protein of approximately 71 kDa that plays critical roles in regulating mitochondrial transport, calcium homeostasis, mitochondrial dynamics, and quality control in neurons. As a molecular adaptor that links mitochondria to the cellular transport machinery, Miro1 is essential for maintaining proper mitochondrial distribution throughout the lengthy axons and dendrites of [neurons](/entities/neurons). The protein has emerged as a key player in the pathogenesis of [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [amyotrophic lateral sclerosis (ALS)](/diseases/amyotrophic-lateral-sclerosis)[@frederick2010][@sheng2015].

Miro1 belongs to a small family of mitochondrial anchoring proteins that includes Miro1 and Miro2 (RHOT2). These proteins are characterized by their unique dual-domain architecture, combining a traditional GTPase domain with calcium-binding EF-hand motifs, enabling them to serve as bidirectional sensors that coordinate mitochondrial function with neuronal activity and metabolic demands.

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Miro1 (RHOT1)</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Miro1 (Mitochondrial Rho GTPase 1)</td></tr>
<tr><td><strong>Gene Symbol</strong></td><td>RHOT1</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9H0K0](https://www.uniprot.org/uniprot/Q9H0K0)</td></tr>
<tr><td><strong>PDB Structures</strong></td><td>5ZKO, 5ZKQ</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>71 kDa</td></tr>
<tr><td><strong>Amino Acids</strong></td><td>618</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Mitochondrial outer membrane (N-terminus in cytosol)</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Miro family (Miro GTPases)</td></tr>
<tr><td><strong>Brain Expression</strong></td><td>High in cortex, hippocampus, substantia nigra, cerebellum</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/ali" style="color:#ef9a9a">ALI</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a></td>
</tr>
<tr>
<td class="label">SciDEX Hypotheses</td>
<td><a href="/hypothesis/h-969bd8e0" style="color:#ce93d8" title="Score: 0.43">Mitochondrial Transfer Pathway Enhanceme...</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">503 edges</a></td>
</tr>
</table>
</div>

Structure and Biochemistry

Domain Architecture

Miro1 possesses a distinctive bipartite structure optimized for its dual roles in mitochondrial anchoring and activity-dependent regulation[@schwarz2013]:

• N-terminal GTPase domain: Contains the traditional GTP-binding motifs (GxxxxGKST and DxxG) characteristic of the Ras GTPase superfamily. This domain is oriented toward the cytosol and mediates interactions with the Milton/Trak adapter proteins that connect mitochondria to molecular motor proteins.
• EF-hand calcium-binding domains: Two EF-hand motifs located in the C-terminal region that sense cytosolic calcium concentrations. These domains enable Miro1 to function as a calcium sensor, modulating mitochondrial transport in response to neuronal activity.
• Transmembrane anchor: A single transmembrane helix near the C-terminus tethers Miro1 to the mitochondrial outer membrane, with the bulk of the protein facing the cytosol.
• Flexible linker region: A proline-rich region between the GTPase and EF-hand domains that provides flexibility for protein-protein interactions.

Oligomerization and Complex Formation

Miro1 forms homodimers through interactions in the GTPase domain. This dimerization is essential for its function as a molecular adaptor. The dimeric Miro1 complex binds to Milton (also known as TRAK1/2 in vertebrates), which in turn links mitochondria to the microtubule-based motor proteins kinesin-1 and cytoplasmic dynein. This tripartite complex—Miro1/Milton/motor protein—forms the core machinery for mitochondrial transport in neurons[@sheng2015].

Normal Function in the Nervous System

Axonal Mitochondrial Transport

Miro1 is essential for proper mitochondrial distribution throughout the extensive axonal and dendritic arborization of neurons. The protein serves as a molecular "power steering" system that:

• Anterograde transport: Engages kinesin-1 motors to move mitochondria from the cell body toward distal synaptic terminals, ensuring that energy-demanding synaptic regions receive adequate mitochondrial supply.
• Retrograde transport: Couples to cytoplasmic dynein for movement toward the cell body, enabling the return of damaged mitochondria for quality control.
• Transport regulation: Modulates the balance between moving and stationary mitochondria based on neuronal activity and metabolic demands.

Calcium Homeostasis

Miro1's EF-hand domains function as highly sensitive calcium sensors that couple neuronal activity to mitochondrial positioning[@saotome2008]:

• Activity-dependent arrest: Elevated cytosolic calcium—occurring during burst firing or glutamatergic neurotransmission—causes Miro1 to transiently arrest mitochondrial movement, trapping mitochondria at sites of high activity where ATP demand is greatest.
• Calcium influx coupling: Mitochondrial positioning via Miro1 directly modulates the efficacy of mitochondrial calcium uptake through the mitochondrial calcium uniporter (MCU), influencing cellular calcium signaling and apoptosis thresholds.
• Synaptic plasticity support: By dynamically redistributing mitochondria to active synapses, Miro1 supports the metabolic demands of long-term potentiation (LTP) and other forms of synaptic plasticity.

Mitochondrial Quality Control

Miro1 plays a central role in linking mitochondrial transport to quality control mechanisms[@bingol2016]:

• PINK1-Parkin mitophagy pathway: Following mitochondrial damage, the serine/threonine kinase PINK1 accumulates on the outer membrane and phosphorylates Miro1. This phosphorylation triggers the recruitment of the E3 ubiquitin ligase Parkin, which tags Miro1 for degradation.
• Miro1 degradation: Damaged mitochondria undergo selective removal of Miro1, disconnecting them from the transport machinery and committing them to autophagic degradation.
• Mitochondrial dynamics coordination: Miro1 interacts with the fission machinery (Drp1) and fusion proteins (Mfn1/2, OPA1) to coordinate mitochondrial quality control with the ongoing dynamics of fission and fusion.

Role in Alzheimer's Disease

Amyloid-Beta Pathogenesis

In Alzheimer's disease, Miro1 dysfunction contributes to several aspects of amyloid-beta (Aβ) pathology[@cheng2019]:

• Mitochondrial transport disruption: Aβ oligomers impair Miro1-mediated mitochondrial transport, leading to reduced mitochondrial density at synapses. This deficit contributes to synaptic energy failure and dysfunction.
• Transport deficits precede cognitive decline: Abnormal mitochondrial transport is observed in early AD stages, suggesting it may be an early pathogenic event rather than a downstream consequence.
• Accelerated pathology: Miro1 knockdown in AD mouse models enhances Aβ pathology and accelerates cognitive deficits, indicating that normal Miro1 function is protective.

Tau-Mediated Effects

The microtubule-associated protein tau, which forms neurofibrillary tangles in AD, also affects Miro1 function:

• Microtubule disruption: Pathological tau species destabilize microtubules, impairing Miro1-dependent mitochondrial transport regardless of Miro1 expression levels.
• Synaptic mitochondrial depletion: The combination of Aβ toxicity and tau pathology creates a synergistic defect in mitochondrial delivery to synapses.

Therapeutic Implications

Miro1 represents a potential therapeutic target in AD:

| Approach | Status | Mechanism |
|----------|--------|-----------|
| Small molecule enhancers | Preclinical | Enhance Miro1-mediated transport |
| Gene therapy | Research | Restore Miro1 expression |
| Microtubule stabilizers | Research | Improve transport efficiency |

Role in Parkinson's Disease

PINK1-Parkin Pathway

Miro1 is a critical substrate in the PINK1-Parkin mitophagy pathway that is disrupted in familial PD[@liu2012][@bingol2016]:

• LRRK2 hyperactivity: Pathogenic LRRK2 mutations (G2019S) cause hyperphosphorylation of Miro1, disrupting the normal process of mitochondrial quality control. The accelerated phosphorylation traps Miro1 in a state that impairs its degradation.
• Impaired mitophagy: In PD patient-derived neurons with PINK1 or Parkin mutations, Miro1 degradation is severely impaired, leading to accumulation of dysfunctional mitochondria that cannot be properly tagged for removal.
• Dopaminergic neuron vulnerability: The unique physiology of dopaminergic neurons—including their pacemaking activity, high mitochondrial demand, and long axons—makes them particularly susceptible to Miro1 dysfunction.

Oxidative Stress

Miro1 function is directly impaired by oxidative stress[@yang2020]:

• Oxidative modification: Reactive oxygen species (ROS) can oxidize cysteine residues in Miro1, altering its GTPase activity and protein-protein interactions.
• Dopaminergic neuron death: In models of PD, oxidative stress-induced Miro1 dysfunction contributes to dopaminergic neuron death through impaired mitochondrial quality control and energy metabolism.

Therapeutic Targeting

Miro1-focused therapeutic strategies for PD include:

• LRRK2 inhibitors: May normalize Miro1 phosphorylation status
• Antioxidants: Protect Miro1 from oxidative modification
• Gene therapy: Deliver functional Miro1 to affected neurons

Role in Amyotrophic Lateral Sclerosis (ALS)

Miro1 abnormalities in ALS contribute to motor neuron vulnerability[@zhang2015]:

• Transport deficits: Mitochondrial transport is severely impaired in ALS motor neurons, with Miro1 playing a central role.
• Mitophagy dysfunction: Impaired Miro1 degradation leads to accumulation of damaged mitochondria in motor neurons.
• ALS gene interactions: Miro1 interacts with ALS-related proteins including TDP-43 (TARDBP) and FUS, suggesting shared pathogenic mechanisms.

Research Models and Methods

Study of Miro1 employs diverse approaches:

• Cell culture: Primary cortical or mesencephalic neurons, motor neurons
• Animal models: Miro1 conditional knockout mice, transgenic AD/PD models
• Human tissue: Postmortem brain samples from AD, PD, and ALS patients
• In vitro systems: Purified protein assays, reconstitutions

See Also

• [Miro2 Protein](/proteins/miro2-protein) — Related paralog
• [PINK1 Gene](/genes/pink1) — Parkin substrate kinase
• [Parkin Gene](/genes/parkin) — E3 ubiquitin ligase
• [Mitochondrial Dynamics](/mechanisms/mitochondrial-dynamics) — Related mechanism
• [Mitophagy Pathway](/mechanisms/mitophagy-pathway) — Quality control
• [Alzheimer's Disease](/diseases/alzheimers-disease) — Primary disease context
• [Parkinson's Disease](/diseases/parkinsons-disease) — Primary disease context

External Links

• [UniProt: RHOT1 (Q9H0K0)](https://www.uniprot.org/uniprot/Q9H0K0)
• [PDB: Miro1 Structures](https://www.rcsb.org/search?searchType=advanced&proteinName=Miro1)
• [GeneCards: RHOT1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=RHOT1)
• [PubMed Search: Miro1 Neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/?term=miro1+neurodegeneration)

References

Related Hypotheses

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

• [Mitochondrial Transfer Pathway Enhancement](/hypothesis/h-969bd8e0) — <span style="color:#ffd54f;font-weight:600">0.43</span> · Target: MIRO1